Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The 5th meeting of the International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) was held in Berlin, Germany and brought to light a huge array of exciting updates within the transplant field, across numerous disease areas.

Explore the expansive and unique information on controversies important to stem cell transplantation and cellular therapies heard at this meeting.

View all videos

COSTEM 2019

24–27 October 2019 | Berlin, Germany

COSTEM 2019

24–27 October 2019 | Berlin, Germany

The 5th meeting of the International Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) was held in Berlin, Germany and brought to light a huge array of exciting updates within the transplant field, across numerous disease areas.

Explore the expansive and unique information on controversies important to stem cell transplantation and cellular therapies heard at this meeting.

View all videos

Transplantation

View all
1:35
Optimal GVHD prophylaxis in T-cell repleted haploidentical transplantation
Christopher Kanakry • 25 Oct 2019
4:25
Post-transplant cyclophosphamide mechanisms
Christopher Kanakry • 26 Oct 2019
1:45
getITD for FLT3-ITD-based MRD monitoring in AML
Lars Bullinger • 26 Oct 2019
3:15
Is haploidentical the best curative option for sickle cell disease?
Miguel Abboud • 26 Oct 2019

GvHD

View all
3:36
Is endothelial protection effective for GVHD, VOD and TMA?
Mohamad Mohty • 26 Oct 2019
1:58
ASCT in the outpatient setting
Rainer Storb

MRD

View all
3:03
Improving AML outcomes
Charles Craddock
3:13
Is MRD monitoring prior to allograft standard in AML?
Michael Heuser • 25 Oct 2019

Multiple Myeloma

View all
2:01
The Chinese CAR-T experience
Peihua Lu • 25 Oct 2019
1:22
MM: stem cell mobilization regimens with and without plerixafor
Nicolaus Kröger • 25 Oct 2019

Lymphoma

View all
2:19
CARs: driving the field forward
Michael Bishop • 26 Oct 2019
3:47
Can CAR-T cells replace ASCT in DLBCL?
Arnon Nagler • 26 Oct 2019

Leukemia

View all
2:45
Optimal preparative regimen for AML
Charles Craddock • 25 Oct 2019
3:07
How will CAR-T cells help us cure Ph+ ALL?
Peter Bader • 25 Oct 2019

Anemia

View all

Sorry, no posts matched your criteria.

The content of VJHemOnc is intended for healthcare professionals